newsfilter
← Latest News
GlobeNewswire·

Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors

BURLINGTON, Mass., July 12, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (NASDAQ:FLXN) today announced the appointment of Utpal Koppikar, Chief Financial Officer of Atara Biotherapeutics, to its Board of Directors. Mr. Koppikar will serve as the